Andrea G. Ludolph, Veit Roessner, Alexander Münchau, Kirsten Müller-Vahl: Tourette-Syndrom und andere Tic-Störungen in Kindheit, Jugend und Erwachsenenalter. In: Dtsch Arztebl Int. Band 109, Nr. 48, 2012, S. 821–828; doi:10.3238/arztebl.2012.0821.
Kirsten R. Müller-Vahl: Treatment of Tourette syndrome with cannabinoids. In: Behavioural Neurology. Band27, Nr.1, Januar 2013, ISSN1875-8584, S.119–124, doi:10.3233/BEN-120276, PMID 23187140.
nih.gov
ncbi.nlm.nih.gov
Kirsten R. Müller-Vahl, Udo Schneider, Heidrun Prevedel, Karen Theloe, Hans Kolbe, Thomas Daldrup, Hinderk M. Emrich: Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. In: The Journal of Clinical Psychiatry. Band64, Nr.4, April 2003, ISSN0160-6689, S.459–465, PMID 12716250.
Kirsten R. Müller-Vahl: Treatment of Tourette syndrome with cannabinoids. In: Behavioural Neurology. Band27, Nr.1, Januar 2013, ISSN1875-8584, S.119–124, doi:10.3233/BEN-120276, PMID 23187140.
Kirsten R. Müller-Vahl, Udo Schneider, Heidrun Prevedel, Karen Theloe, Hans Kolbe, Thomas Daldrup, Hinderk M. Emrich: Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. In: The Journal of Clinical Psychiatry. Band64, Nr.4, April 2003, ISSN0160-6689, S.459–465, PMID 12716250.
Kirsten R. Müller-Vahl: Treatment of Tourette syndrome with cannabinoids. In: Behavioural Neurology. Band27, Nr.1, Januar 2013, ISSN1875-8584, S.119–124, doi:10.3233/BEN-120276, PMID 23187140.